Antibiotics, Analgesic Sedatives, and Antiseizure Medications Frequently Used in Critically Ill Neonates: A Narrative...

Area of Science:

• Neonatal pharmacology
• Pediatric critical care
• Infectious disease

Background:

• Preterm and sick neonates frequently receive antibiotics, analgesics/sedatives, and antiseizure medications.
• These neonates face high risks of nosocomial infections and central nervous system complications, necessitating prompt treatment.
• Significant variability in medication use underscores a lack of robust neonatal studies on efficacy and safety.

Purpose of the Study:

• To update knowledge on antimicrobial, analgesic/sedative, and antiseizure medication use in neonates.
• To identify evidence gaps in pharmacokinetics, indications, safety, dosage, and guidelines.
• To explore the impact of early antibiotic exposure on the neonatal microbiome and long-term health.

Main Methods:

• Comprehensive literature review focusing on neonatal medication use.
• Analysis of current evidence and identification of knowledge gaps.
• Discussion of pharmacokinetic data, safety profiles, and dosing recommendations.

Main Results:

• Significant variability exists in neonatal medication practices, indicating a need for more research.
• Early antibiotic exposure may influence the intestinal microbiome, potentially linking to long-term immune and neurodevelopmental issues.
• Pathogen resistance to antimicrobials and antifungals is a growing concern.

Conclusions:

• Optimizing neonatal medication use requires addressing current evidence gaps and ethical considerations.
• Understanding the long-term effects of early antibiotic exposure is crucial for neonatal health.
• Strategies for preventing and managing antimicrobial resistance are essential for improved neonatal care.